![Tom Hochuli](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Postes actifs de Tom Hochuli
Sociétés | Poste | Début | Fin |
---|---|---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Directeur/Membre du Conseil | 01/01/2020 | - |
Directeur Général | 01/01/2020 | - | |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | President | 30/01/2024 | - |
Historique de carrière de Tom Hochuli
Statistiques
Internationale
Allemagne | 2 |
Etats-Unis | 2 |
Opérationnelle
Director/Board Member | 1 |
Chief Executive Officer | 1 |
President | 1 |
Sectorielle
Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 2 |
---|---|
Vibalogics GmbH
![]() Vibalogics GmbH BiotechnologyHealth Technology Vibalogics GmbH develops therapeutic and prophylactic vaccines and biological products. The company is headquartered in Cuxhaven, Germany. | Health Technology |
Be The Match Biotherapies
![]() Be The Match Biotherapies BiotechnologyHealth Technology Part of The Marrow Foundation, Be The Match Biotherapies is a company that partners with cell and gene therapy companies to provide customizable services to support the entire end-to-end cell therapy supply chain. The company is based in Minneapolis, MN. The company has extensive experience providing cellular source material consented for research, clinical and commercial use. The company was founded in 2016. The CEO is Amy L. Ronneberg. | Health Technology |
- Bourse
- Insiders
- Tom Hochuli
- Expérience